Healthtech company Insightec has signed a credit facility worth up to $200 million with Perceptive Advisors and Community Fund.
Insightec received $100 million at the signing of the credit facility, with another $100 million potentially available in tranches through 2024. The new line of credit will be used to explore Insightec incisionless neurosurgery technology, according to a Sept. 1 Insightec news release.
"This financing allows Insightec to invest in driving adoption of incisionless neurosurgery to treat patients with Essential Tremor and Parkinson's Disease, while continuing to advance innovation and clinical trials for expanded applications of the company's technology in neuro-oncology and other neurological conditions," said Maurice Ferre, MD, Insightec CEO and chair. "We are pleased to have continued support from Perceptive Advisors and Community Fund. Insightec is a true global company. We are focused on supporting and growing our world class customer base of medical centers across the Americas, Europe, and Asia."